Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Rocket
2000.7000 7.70 (0.39%)
NSE Nov 16, 2026 15:31 PM
Volume: 214.3K
 

2000.70
0.39%
Emkay
Following the slump in FY23, DLPL has registered revenue/EBITDA/PAT CAGR of 10%/19%/43%, respectively, over the last two years.
Dr. Lal Pathlabs has gained 24.82% in the last 6 Months
More from Dr. Lal Pathlabs Ltd.
Recommended